Inventories (Details) $ in Thousands |
6 Months Ended | |
|---|---|---|
|
Nov. 30, 2021
USD ($)
item
|
May 31, 2021
USD ($)
|
|
| Inventory Disclosure [Abstract] | ||
| Raw materials | $ 22,536 | $ 28,085 |
| Work in progress | 66,021 | 65,394 |
| Total | $ 88,557 | $ 93,479 |
| Number of portions of Biologic License Application ("BLA") resubmitted | item | 2 |
| X | ||||||||||
- Definition The number of portions of Biologic License Application ("BLA") that have been resubmitted for approval. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|